Live Markets
Tuesday, July 28, 2026·George Town, KY·29°·Partly Cloudy
Markets Open · NYSE·Newsletter·Masthead·
VOL. XII · NO. 117Established MMXIV · George Town, Grand CaymanAtlantic Edition · $4.50

The Cayman Journal

Finance · Business · Technology · Caribbean & Global Affairs
Markets · Healthcare

biote Corp. (BTMD)

NGM · Medical Care Facilities

$2.24-0.09 (-3.86%)Quote refreshed

Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires

Market Cap
$79.6M
P/E (TTM)
5.46
EPS
$0.41
Div Yield
52W Range
$1.27–$4.75
Beta
1.66

Company overview

Next earnings: 2026-08-05(8d)

biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and meet other administrative requirements; inventory management software to facilitate ordering and inventory control; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female patients. The company was founded in 2012 and is headquartered in Irving, Texas.

Peers in Medical Care Facilities

All in industry →

Recent press releases

April 2026

3 months ago8-KHealthcare

biote Corp. — 8-K Filing

BTMDbiote Corp.

# 🧾 What This Document Is This is an 8-K filing, which is a report companies use to announce major news to investors. Attached to it is a full investor presentation (the slides starting with "Transforming Healthy Aging"). Think of the 8-K as the official cover letter, and the presentation as the de

Read summaryView on SEC EDGAR
3 months agoDEF 14AHealthcare

biote Corp. — DEF 14A Filing

BTMDbiote Corp.

# 🧾 What This Document Is This is a **DEF 14A, or "Proxy Statement."** It's an official notice and information packet sent to shareholders before a company's annual meeting. Its job is to tell you what will be voted on, give you the details you need to make informed decisions, and report on key gov

Read summaryView on SEC EDGAR

SEC filings

All filings →
2 recent filings shown in the timeline above. View all SEC filings →

biote Corp. has no reported insider trades in the last 90 days.

Institutional holders

All holders →
As of 2025-12-31 · prior 2025-09-30
13,272 sh-31.0%
4,548,127 sh0.0%
2,283,791 sh0.0%
1,768,976 sh+1.5%
1,444,733 sh+1.2%
146,250 sh● NEW
69,655 sh-52.5%
2,796 sh-95.8%

People at biote Corp.

All people →

Quarterly financials

Full financials →
Revenue trend
03/25
$1.3M
NI $13.7M
06/25
$535.0K
NI $3.2M
09/25
$48.0M
NI $8.2M
RevenueNI = Net Income
EPS trend (diluted)
Latest: $0.22
Prior: $0.10
Revenue sparkline